Northfield Hospital & Clinics is actively contacting patients who may have received either of two medications manufactured by New England Compounding Center (NECC), a Massachusetts pharmaceutical firm linked to a recent outbreak of fungal meningitis.
The medications, Nubain 10 mg/ml injectable, and Lidocaine/Epinephrine/Tetracaine Gel, have been used at Northfield Hospital & Clinics since June of 2012. Hospital officials say fewer than 125 patients received either of the medications in question.
The two medications have not been linked directly to the fungal meningitis outbreak, but following an inspection of the NECC, the Federal Drug Administration (FDA) said the sterility of any injectable drugs produced by the firm is of significant concern. The FDA said: “out of an abundance of caution, patients who received these products should be alerted to the potential risk of infection.”
Fungal infections are difficult to diagnose. They often take many months to produce signs of infection. Patients who have received the medications are asked to watch for these signs:
- Fever greater than 100 Degrees Fahrenheit
- Localized redness, swelling or warmth at injection
- Neck stiffness.
If patients exhibit these symptoms, they are advised to see their medical provider.
Northfield Hospital & Clinics has never used the steroid medication linked to the fungal meningitis outbreak. All products made by NECC have been recalled and pulled from the shelves at Northfield Hospital & Clinics.
If you have any concerns regarding these medications, please call Northfield Hospital at 507-646-1000.